Literature DB >> 3547919

Effectiveness of oral acyclovir prophylaxis in renal transplant recipients.

M Stoffel, J P Squifflet, Y Pirson, M Lamy, G P Alexandre.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3547919

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  6 in total

Review 1.  Clinically significant drug interactions with cyclosporin. An update.

Authors:  C Campana; M B Regazzi; I Buggia; M Molinaro
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

2.  A randomized double-blind placebo controlled trial of oral acyclovir in renal allograft recipients.

Authors:  W F Schlech; N Meagher; A D Cohen; P Belitsky; A Macdonald; J C Leblanc
Journal:  Can J Infect Dis       Date:  1993-03

3.  Reversible renal failure in renal transplant patients receiving oral acyclovir prophylaxis.

Authors:  T Ahmad; M Simmonds; A G McIver; M E McGraw
Journal:  Pediatr Nephrol       Date:  1994-08       Impact factor: 3.714

4.  Acyclovir susceptibilities of herpes simplex virus strains isolated from solid organ transplant recipients after acyclovir or ganciclovir prophylaxis.

Authors:  G Boivin; A Erice; D D Crane; D L Dunn; H H Balfour
Journal:  Antimicrob Agents Chemother       Date:  1993-02       Impact factor: 5.191

5.  Prospective study of renal transplant infections in 50 consecutive patients.

Authors:  F Martinez-Marcos; J Cisneros; M Gentil; G Algarra; P Pereira; J Aznar; J Pachon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-12       Impact factor: 3.267

Review 6.  Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  J J O'Brien; D M Campoli-Richards
Journal:  Drugs       Date:  1989-03       Impact factor: 9.546
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.